SCHEMBL7489140

SCHEMBL7489140

C=CCOc1cc(F)cc(F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT6A Q92794 1/20 0.43
MAPT P10636 2/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CA12 O43570 5/20 0.40
CA1 P00915 5/20 0.40
CA9 Q16790 5/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
MAOA P21397 2/20 0.40
MAOB P27338 2/20 0.40
ADRA2A P08913 2/20 0.40
ADRA2B P18089 2/20 0.40
ADRA2C P18825 2/20 0.40
SOD1 P00441 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.36
HTR2A P28223 3/20 0.36
HTR2C P28335 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1522059 0.88 KAT6A (0.40) KAT6AMAPTMEN1LMNAKMT2A
SCHEMBL8271143 0.86 KAT6A (0.39) KAT6AMAPTMEN1LMNAKMT2A
SCHEMBL2528967 0.86 KAT6A (0.39) KAT6AMAPTMEN1LMNAKMT2A
SCHEMBL14201394 0.86 KAT6A (0.43) KAT6AMAPTMEN1LMNAKMT2A
SCHEMBL17514649 0.84 KAT6A (0.40) KAT6AMAPTMEN1LMNAKMT2A
SCHEMBL16141852 0.83 CYP4F2 (0.50) KAT6AMAPTMEN1LMNAKMT2A
SCHEMBL13006437 0.83 KAT6A (0.38) KAT6AMAPTMEN1LMNAKMT2A
SCHEMBL2524244 0.83 KAT6A (0.40) KAT6AMAPTMEN1LMNAKMT2A
SCHEMBL3818350 0.83 MAPT (0.47) MAPTMEN1LMNAKMT2ASMN1; SMN2
SCHEMBL3468805 0.83 SOD1 (0.37) KAT6AMAOAMAOBSOD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3145512-B1 SUBSTITUTED ETHYNYL HETEROBICYCLIC COMPOUNDS AS TYROSINE KINASE INHIBITORS JIANGSU HENGRUI MEDICINE CO (CN) 2019-07-17 EP disclosed
EP-1173170-A4 PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO INC (US) 2002-05-29 EP disclosed
EP-1173170-A1 PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Merck & Co., Inc. (US) 2002-01-23 EP disclosed
US-6265434-B1 ANTIINFLAMMATORY AGENTS MERCK & CO., INC. 2001-07-24 US disclosed
WO-2000059503-A1 PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-10-12 WO disclosed